SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-8A
NOTIFICATION OF REGISTRATION
FILED PURSUANT TO SECTION 8(a) OF THE
INVESTMENT COMPANY ACT OF 1940
The undersigned investment company hereby notifies the Securities
and Exchange Commission that it registers under and pursuant to the provisions
of Section 8(a) of the Investment Company Act of 1940 and in connection with
such notification of registration submits the following information:
- --------------------------------------------------------------------------------
Name: Orbitex Life Sciences & Biotechnology Fund, Inc.
Address of Principal Business Office (No. & Street, City, State, Zip Code):
410 Park Avenue
New York, New York 10022
Telephone Number (including area code): (212) 891-7900
Name and address of agent for service of process:
M. Fyzul Khan, Legal Counsel
Orbitex Management, Inc.
410 Park Avenue, 18th Floor
New York, New York 10022
copies to:
Max Berueffy, Esq. Leonard B. Mackey, Jr., Esq.
American Data Services, Inc. Clifford Chance Rogers & Wells LLP
150 Motor Parkway 200 Park Avenue
Hauppauge, NY 11788-0132 New York, New York 10166
Check Appropriate Box:
Registrant is filing a Registration Statement pursuant to Section 8(b) of the
Investment Company Act of 1940 concurrently with the filing of Form N-8A:
[GRAPHIC OMITTED] Yes |X| No |_|
- --------------------------------------------------------------------------------
<PAGE>
SIGNATURE
Pursuant to the requirements of the Investment Company Act of 1940,
as amended, the registrant has caused this notification of registration to be
duly signed on its behalf in the City of New York and State of New York on the
10th day of April, 2000.
[SEAL]
ORBITEX LIFE SCIENCES & AND
BIOTECHNOLOGY FUND, INC.
Attest: By:____________________________________
M. Fyzul Khan, Vice President
______________________________
Catherine McCabe,
Assistant Secretary
